Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
265 studies found for:    Open Studies | "Colitis, Ulcerative"
Show Display Options
Rank Status Study
21 Recruiting Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).
Condition: Colitis, Ulcerative
Intervention: Biological: Golimumab
22 Recruiting An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab;   Drug: Adalimumab placebo;   Drug: Adalimumab;   Drug: Vedolizumab placebo
23 Recruiting Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
Conditions: Colitis, Ulcerative;   Crohn Disease
Intervention: Drug: Vedolizumab
24 Recruiting Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab IV 300 mg;   Drug: Placebo IV;   Drug: Vedolizumab SC 108 mg;   Drug: Placebo SC
25 Recruiting A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Interventions: Drug: LT-02;   Drug: LT-02 Placebo
26 Recruiting Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
27 Unknown  Melatonin & Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Melatonin;   Other: Placebo
28 Not yet recruiting Ulcerative Colitis Relapse Prevention by Prebiotics
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Synergy-1;   Dietary Supplement: Maltodextrin
29 Recruiting Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Infliximab
30 Unknown  Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population
Conditions: Ulcerative Colitis;   Crohn's Disease
Intervention:
31 Recruiting Remote Ischemic Conditioning in Patients With Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Gastrointestinal Diseases;   Pathologic Processes;   Intestinal Diseases;   Inflammatory Bowel Diseases
Intervention: Device: AutoRIC device
32 Recruiting Low Dose IL-2 for Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Interleukin-2 (aldesleukin).
33 Recruiting Thermography in Surveillance of Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: Thermography;   Procedure: Colonoscopy
34 Recruiting Study of Cimzia for the Treatment of Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Cimzia
35 Unknown  Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Aloe Barbadensis Miller;   Dietary Supplement: placebo water
36 Recruiting Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: CP-690,550
37 Unknown  Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Procedure: Colonoscopy biopsy;   Other: stool collection;   Procedure: colonoscopy biopsy
38 Recruiting Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention: Biological: Fecal Microbiota Transplantation
39 Unknown  Role of Healthy Bacteria in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Other: Control;   Drug: Probiotic
40 Not yet recruiting Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis
Conditions: Ulcerative Colitis;   Cytomegalovirus Infections
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years